These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37387388)

  • 1. A comprehensive review and meta-analysis of suPAR as a predictor of acute kidney injury.
    Jankowski L; Pruc M; Gasecka A; Chmielewski J; Wojcik T; Szarpak L; Kowalczyk M
    Ann Agric Environ Med; 2023 Jun; 30(2):364-368. PubMed ID: 37387388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive value of suPAR in AKI: a systematic review and meta-analysis.
    Huang Y; Huang S; Zhuo X; Lin M
    Clin Exp Nephrol; 2023 Jan; 27(1):1-11. PubMed ID: 36469196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of soluble urokinase-type plasminogen activator receptor in predicting sepsis-associated acute kidney injury.
    Zhang W; Gu Y; Zhou J; Wang J; Zhao X; Deng X; Li H; Yan L; Jiao X; Shao F
    Ren Fail; 2024 Dec; 46(1):2307959. PubMed ID: 38289005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Soluble Urokinase Plasminogen Activator Receptor as a Predictive Indicator for COVID-19-Associated Acute Kidney Injury and Mortality: Clinical and Bioinformatics Analysis.
    Abdellatif HAA; Sultan BO; Nassar HM; Gomaa MEE; Sakr MG; Riad E; Al-Harbi AI; Abdulhakim JA; Fawzy MS; Abd El-Fadeal NM
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated Soluble Urokinase Plasminogen Activator Receptor and Proenkephalin Serum Levels Predict the Development of Acute Kidney Injury after Cardiac Surgery.
    Mossanen JC; Pracht J; Jansen TU; Buendgens L; Stoppe C; Goetzenich A; Struck J; Autschbach R; Marx G; Tacke F
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Predictive Value of Soluble Urokinase-Type Plasminogen Activator Receptor in Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention.
    Qin Y; Qiao Y; Wang D; Yan G; Tang C; Ma G
    Int J Gen Med; 2021; 14():6497-6504. PubMed ID: 34675617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of suPAR and hsCRP on acute kidney injury after cardiac surgery.
    Rasmussen SR; Nielsen RV; Møgelvang R; Ostrowski SR; Ravn HB
    BMC Nephrol; 2021 Apr; 22(1):120. PubMed ID: 33827466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. suPAR as a marker of infection in acute kidney injury - a prospective observational study.
    Hall A; Crichton S; Varrier M; Bear DE; Ostermann M
    BMC Nephrol; 2018 Aug; 19(1):191. PubMed ID: 30071826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Urokinase Receptor (SuPAR) in COVID-19-Related AKI.
    Azam TU; Shadid HR; Blakely P; O'Hayer P; Berlin H; Pan M; Zhao P; Zhao L; Pennathur S; Pop-Busui R; Altintas I; Tingleff J; Stauning MA; Andersen O; Adami ME; Solomonidi N; Tsilika M; Tober-Lau P; Arnaoutoglou E; Keitel V; Tacke F; Chalkias A; Loosen SH; Giamarellos-Bourboulis EJ; Eugen-Olsen J; Reiser J; Hayek SS;
    J Am Soc Nephrol; 2020 Nov; 31(11):2725-2735. PubMed ID: 32963090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury.
    Nusshag C; Wei C; Hahm E; Hayek SS; Li J; Samelko B; Rupp C; Szudarek R; Speer C; Kälble F; Schaier M; Uhle F; Schmitt FC; Fiedler MO; Krautkrämer E; Cao Y; Rodriguez R; Merle U; Eugen-Olsen J; Zeier M; Weigand MA; Morath C; Brenner T; Reiser J
    JCI Insight; 2023 Apr; 8(7):. PubMed ID: 37036003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations between soluble urokinase plasminogen activator receptor (suPAR) concentration and psychiatric disorders - A systematic review and meta-analysis.
    Murphy J; Zierotin A; Mongan D; Healy C; Susai SR; O'Donoghue B; Clarke M; O'Connor K; Cannon M; Cotter DR
    Brain Behav Immun; 2024 Aug; 120():327-338. PubMed ID: 38857636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble Urokinase Receptor and Acute Kidney Injury.
    Hayek SS; Leaf DE; Samman Tahhan A; Raad M; Sharma S; Waikar SS; Sever S; Camacho A; Wang X; Dande RR; Ibrahim NE; Baron RM; Altintas MM; Wei C; Sheikh-Hamad D; Pan JS; Holliday MW; Januzzi JL; Weisbord SD; Quyyumi AA; Reiser J
    N Engl J Med; 2020 Jan; 382(5):416-426. PubMed ID: 31995687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit.
    Reisinger AC; Niedrist T; Posch F; Hatzl S; Hackl G; Prattes J; Schilcher G; Meißl AM; Raggam RB; Herrmann M; Eller P
    Sci Rep; 2021 Sep; 11(1):17476. PubMed ID: 34471146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysis.
    Matuszewski M; Ładny J; Rafique Z; Peacock F; Pruc M; Gasecka A; Szwed P; Jankowski L; Chmielewski J; Panasiuk L; Szarpak L
    Ann Agric Environ Med; 2023 Mar; 30(1):142-147. PubMed ID: 36999867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of soluble urokinase-type plasminogen activator receptor in patients with acute coronary syndrome: A systematic review and meta-analysis.
    Pruc M; Jannasz I; Swieczkowski D; Procyk G; Gasecka A; Rafique Z; Chirico F; Bragazzi NL; Jaguszewski MJ; Wysocki J; Szarpak L
    Cardiol J; 2024; 31(4):564-572. PubMed ID: 37772350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Urokinase-Type Plasminogen Activator Receptor Levels as a Predictor of Kidney Replacement Therapy in Septic Patients with Acute Kidney Injury: An Observational Study.
    Skalec T; Adamik B; Kobylinska K; Gozdzik W
    J Clin Med; 2022 Mar; 11(6):. PubMed ID: 35330042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum soluble urokinase type plasminogen activated receptor and focal segmental glomerulosclerosis: a systematic review and meta-analysis.
    Shuai T; Pei Jing Y; Huang Q; Xiong H; Liu J; Zhu L; Yang K; Jian L
    BMJ Open; 2019 Oct; 9(10):e031812. PubMed ID: 31594897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Serum Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in FSGS: A Meta-Analysis.
    Lee JM; Yang JW; Kronbichler A; Eisenhut M; Kim G; Lee KH; Shin JI
    J Immunol Res; 2019; 2019():5679518. PubMed ID: 31089477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical value of suPAR in diagnosis and prediction for patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.
    Huang Q; Xiong H; Shuai T; Wang Y; Zhang C; Zhang M; Zhu L; Lu J; Liu J
    Ther Adv Respir Dis; 2020; 14():1753466620938546. PubMed ID: 32643535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Shuai T; Yan P; Xiong H; Huang Q; Zhu L; Yang K; Liu J
    Biomed Res Int; 2019; 2019():6927456. PubMed ID: 31886242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.